Predictors of Conduction Disturbances Requiring a Late Permanent Pacemaker

This analysis shows that baseline right bundle branch block and increased PR length after transcatheter aortic valve replacement (TAVR) are independent predictors of advanced conduction disturbances requiring late pacemaker implantation. A simple electrocardiography can detect these potentially fatal conduction disturbances that might happen more than 48 hours after TAVR.

Data from consecutive TAVR patients from one center (Milan, Italy) were gathered between 2007 and 2015. Delta PR and delta QRS were defined as the difference between the last PR and QRS length available 48 hrs. after TAVR and baseline PR and QRS length.

 

The study looked at data from 740 patients, excluding 78 that already had a pacemaker and 51 that had received one less than 48 hrs. after TAVR, which left 611 patients for final analysis.

 

8.8% developed conduction disturbances requiring a pacemaker ≥48h after procedure. Patients requiring late pacemaker implantation had wider QRS (113 ± 25 ms vs. 105 ± 23 ms; p=0.009), higher prevalence of right bundle branch block (12.9% vs. 5.3%; p=0.026) and were more likely to receive a self-expandable valve (51.8% vs. 31.9%; p=0.003).


Read also: EXCEL Sub-Analysis: Angioplasty vs. Surgery in Chronic Renal Insufficiency.


Delta PR was 40 ± 51 ms (p=0.0001) and delta QRS was 22 ± 61 ms (p=0.001).

 

Multivariable analysis showed that baseline right bundle branch block had between 3.5 and 4 times higher risk of getting a pacemaker (p=0.0001) and delta PR increased this risk by 1.3 times every 10 ms (p=0.0001).

 

Conclusion

The evidence consolidates in favor of a simple ECG to detect patients at higher risk of requiring late pacemaker implantation after TAVR. Baseline bundle branch block and increased PR are predictors of late advanced conduction disturbances.

 

Original title: Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 hs) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement.

Reference: Antonio Mangieri et al. J Am Coll Cardiol Intv 2018;11:1519–26.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....